Skip to main content

Advertisement

Log in

ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Availability of Data and Material (Data Transparency)

Institutional quality improvement approval was obtained prior to data review and manuscript preparation.

Funding

The authors acknowledge philanthropic support from Ben-Liou Yao and Amy Chen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tari A. King MD.

Ethics declarations

AW reports that her institution, Brigham and Women's Hospital, has a sponsored research agreement with Myriad Laboratories, Inc. EAM reports compensated service on scientific advisory boards for AstraZeneca, Exact Sciences, Merck, and Roche/Genentech; uncompensated service on steering committees for Bristol Myers Squibb, Lilly, and Roche/Genentech; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. EAM reports the following nonfinancial interests, nonremunerated activities: Board of Directors for the American Society of Clinical Oncology and Scientific Advisor for Susan G. Komen for the Cure Foundation. TAK reports receiving speakers honoraria and compensated service on the scientific Advisory Board for Exact Sciences and compensated service from Besins Healthcare Global Advisory Board outside the submitted work. The remaining authors declare no conflicts of interest.

Ethics Approval

Institutional quality improvement approval was obtained prior to data review and manuscript preparation.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kantor, O., Weiss, A., Burstein, H.J. et al. ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes. Ann Surg Oncol 29, 7683–7684 (2022). https://doi.org/10.1245/s10434-022-12081-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12081-3

Navigation